| Multiparametric magnetic resonance imaging-ultrasound fusion biopsy improves but does not replace standard template biopsy for the detection of prostate cancer N Hanna, MF Wszolek, A Mojtahed, E Nicaise, B Wu, ... The Journal of Urology 202 (5), 944-951, 2019 | 36 | 2019 |
| Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification A Yu, T Yamany, A Mojtahed, N Hanna, E Nicaise, M Harisinghani, CL Wu, ... Urologic Oncology: Seminars and Original Investigations 40 (2), 59. e1-59. e5, 2022 | 11 | 2022 |
| Recent trends in the diagnostic and surgical management of benign prostatic hyperplasia in the US from 2004 to 2017: annual changes in the selection of treatment options and … F Del Giudice, JK Oh, S Basran, E Nicaise, PH Song, W Kim, SY Kim, ... Applied Sciences 12 (17), 8697, 2022 | 8 | 2022 |
| Creatinine to cystatin-C ratio in renal cell carcinoma: a clinically pragmatic prognostic factor and sarcopenia biomarker BN Schmeusser, H Biermann, EH Nicaise, AA Ali, DH Patil, E Midenberg, ... The Oncologist 28 (12), e1219-e1229, 2023 | 2 | 2023 |
| Influence of body composition on the perioperative and survival outcomes of renal cell carcinoma EH Nicaise, BN Schmeusser, YB Shah, MA Bilen, K Ogan, VA Master The Korean Journal of Urological Oncology 21 (3), 183-199, 2023 | 2 | 2023 |
| Timing Considerations for Artificial Urinary Sphincter Implantation Post-Pelvic Radiotherapy K Malshy, S Marthi, R Ortiz, E Nicaise, B Golijanin, K Miller, L Hartsell, ... Urology, 2024 | | 2024 |
| Factors Associated with Completion and Improvement Following Integrative Oncology Acutherapy in a Racially-Diverse Population MG Zelaya, EH Nicaise, B Hartsoe, M Melikian, A Catic, D Patil, ... | | 2024 |
| Comparing the lifespan of virgin artificial urinary sphincters in radiated patients: transcorporal vs. standard placement K Malshy, S Marthi, R Ortiz, E Nicaise, B Golijanin, K Miller, L Hartsell, ... World Journal of Urology 42 (1), 391, 2024 | | 2024 |
| Incidence and Survival of Extramammary Paget’s Disease from the Surveillance, Epidemiology, and End Results (SEER) Database EH Nicaise, M McNamara, BN Schmeusser, G Palmateer, D Patil, J Petros, ... Surgical Oncology Insight, 100064, 2024 | | 2024 |
| Differences in preoperative frailty assessment of surgical candidates by sex, age, and race EH Nicaise, G Palmateer, BN Schmeusser, C Futral, Y Liu, S Goyal, ... Surgery Open Science 19, 172-177, 2024 | | 2024 |
| Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy EH Nicaise, BN Schmeusser, A Ali, E Midenberg, AR Palacios, B Hartsoe, ... Clinical Genitourinary Cancer 22 (3), 102056, 2024 | | 2024 |
| Integrative Approach to Nephro-Cutaneous Fistula Wound Healing: Case Report B Hartsoe, M Srivastava, E Nicaise, B Schmeusser, A Bausum, VA Master Traditional Medicine and Modern Medicine, 2024 | | 2024 |
| PD18-08 TUMOR SIZE REDUCTION (≥ 10%) RESULTING FROM PRE-SURGICAL SYSTEMIC THERAPY PREDICTS IMPROVED SURVIVAL FOLLOWING CYTOREDUCTIVE NEPHRECTOMY DD Shapiro, JA Karam, VA Master, PE Spiess, CC Peyton, B Dolan, ... Journal of Urology 211 (5S), e435, 2024 | | 2024 |
| MP51-10 FUNCTIONAL OUTCOMES IN RENAL MASS PATIENTS UNDERGOING ACTIVE SURVEILLANCE VERSUS PARTIAL NEPHRECTOMY: A PROPENSITY SCORE MATCHED ANALYSIS MV Nguyen, B Lane, KL Yuen, C Saitta, Y Fujii, E Nicaise, C Cerrato, ... Journal of Urology 211 (5S), e845, 2024 | | 2024 |
| PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS … DD Shapiro, JA Karam, VA Master, PE Spiess, CC Peyton, SP Psutka, ... Journal of Urology 211 (5S), e433, 2024 | | 2024 |
| MP36-17 RENAL FUNCTIONAL IMPROVEMENT AFTER PARTIAL NEPHRECTOMY: PREDICTORS AND CONSEQUENCES KL Yuen, C Saitta, Y Fujii, E Nicaise, R Autorino, A Minervini, G Tuderti, ... Journal of Urology 211 (5S), e599, 2024 | | 2024 |
| MP10-11 A PROPENSITY SCORE-MATCHED ANALYSIS OF OUTCOMES OF NEOADJUVANT AND ADJUVANT SYSTEMIC THERAPY IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA: IMPACT OF TIMING OF THERAPY … C Saitta, MV Nguyen, K Hakimi, D Patil, H Tanaka, JA Afari, J Cortes, ... Journal of Urology 211 (5S), e142, 2024 | | 2024 |
| MP45-20 THE ASSOCIATION BETWEEN PRESCRIPTION MEDICATIONS AND KIDNEY STONE PREVALENCE AMONG US ADULTS FE Glover, KF Al, JP Burton, EH Nicaise, V Master, K Ogan, A Ha, M Scott, ... The Journal of Urology 211 (5S), e751, 2024 | | 2024 |
| PD18-06 VALIDATION OF THE SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY (SCREEN) MODEL USING AN INDEPENDENT CONTEMPORARY MULTI-CENTER COHORT EJ Abel, VA Master, PE Spiess, CC Peyton, SP Psutka, JD Raman, ... Journal of Urology 211 (5S), e434, 2024 | | 2024 |
| MP10-16 LINEAR MUSCLE SEGMENTATION FOR METASTATIC RENAL CELL CARCINOMA: CHANGES IN CLINIC-FRIENDLY ESTIMATION PREDICT SURVIVAL IN PATIENTS FOLLOWING CYTOREDUCTIVE NEPHRECTOMY EH Nicaise, BN Schmeusser, A Ali, E Midenberg, AR Palacios, E Kearns, ... The Journal of Urology 211 (5S), e146, 2024 | | 2024 |
